McKesson Ventures
  • Portfolio
  • News & Insights
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

BranchLab Raises $26M Series A Led by McKesson Ventures to Bring AI to Pharma Commercialization

by McKesson Ventures | May 13, 2026 | Press Releases

AI-based biopharma commercialization company BranchLab recently announced the completion of a $26 million Series-A funding round, led by McKesson Ventures and with additional participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures, bringing the...

Recent Posts

  • Latent Expands AI Platform to Unlock Access to a New Generation of Medicines
  • Komodo Health Wins 2026 Fierce AI Innovation Award for Commercial Strategy & Launch from Fierce Pharma
  • Silver and LYNX Launch Production AI Claims Automation to Help TPAs Modernize Claims Processing
  • HarmonyCares Ranks Among Medicare’s Top ACO REACH Performers for 2024
  • UNC Health Scales Medication Access By Over 45% Without Adding Headcount Using Latent Health’s Pharmacy Intelligence Platform
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings